Heidi Health Revenue, Valuation, Funding & Investors

Heidi Health is valued at $901M as of September 2026, a 18.0x revenue multiple. Heidi Health revenue was $50M, as disclosed with its latest round.

Last Heidi Health valuation

$901M

Series C · Sep 2026

Last Heidi Health funding round

$340M

Series C · Sep 2026

Heidi Health revenue

$50M

Series C · Sep 2026

Key investors in Heidi Health

  • Blackbird Ventures
  • Possible Ventures
  • Archangel Ventures
  • Headline
  • Point72 Ventures
  • HESTA

Heidi Health Overview

About Heidi Health

Heidi Health is a Sydney-based health technology company that delivers an AI-driven ambient scribing platform for healthcare providers. The software records and transcribes clinician-patient conversations in real time, producing structured clinical notes, referral letters, patient summaries, and billing codes like ICD-10 and CPT. It features customizable templates, live editing capabilities, and seamless integrations with electronic health record systems such as Best Practice, Communicare, and Epic. Compliant with HIPAA, GDPR, and Australian privacy laws, the platform serves general practitioners, specialists in cardiology, dermatology, and mental health, plus allied health professionals across Australia, New Zealand, the United Kingdom, and the United States.


Founded

2019

HQ

AustraliaSydney

Status

Privately held

Customer focus

B2B

Revenue model

Subscription

Revenue

$50M (Sep 2026)

Valuation

$901M (Sep 2026)

Heidi Health Valuation

Heidi Health is currently valued at $901M, based on its Series C in September 2026.

The $340M round was led by Blackbird Ventures and General Catalyst, with participation from Point72 Ventures, Phoenix Court and Headline.

Heidi Health's valuation has grown 62x from $15M at its seed round in August 2021 to $901M in September 2026, across 3 priced rounds.

Heidi Health valuation by funding round

Revenue multiple
Heidi Health valuation by funding round
DateStageValuationRevenue Multiple
Sep 2026Series C$901M18.0x
Oct 2025Series B$465M31.0x
Aug 2021Seed$15M-

Heidi Health Revenue

Heidi Health's latest recorded revenue is $50M, as of its Series C in September 2026. At a $901M valuation, that implies a 18.0x revenue multiple.

Revenue grew from $15M in October 2025 to $50M in September 2026, while the revenue multiple moved from 31.0x to 18.0x.

Heidi Health revenue by funding round

Heidi Health revenue and valuation multiple by funding round
DateRevenue *ValuationRevenue MultipleStage
Sep 2026$50M$901M18.0xSeries C
Oct 2025$15M$465M31.0xSeries B

* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.

Heidi Health Funding History

Heidi Health has raised a total of $431M across 5 funding rounds.

Heidi Health's first fundraising round was a $4M seed round in August 2021. The most recent completed round was a $340M Series C in September 2026.

Heidi Health funding rounds

Heidi Health funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Sep 2026Series CBlackbird Ventures (lead); General Catalyst (lead); Point72 Ventures; Phoenix Court; Headline$340M$901MHeidi closed a US$100 million Series C led by Blackbird Ventures, with participation from Phoenix Court, Point72 Private Investments and Headline, alongside a separate US$240 million growth investment from General Catalyst’s Customer Value Fund, bringing total new funding to US$340 million and valuing the company at US$900 million. The financing was framed as capital to scale Heidi’s AI care partner across health systems globally, deepen adoption in hospitals and health systems, and support rapid commercial expansion, including further go-to-market investment and international growth. Heidi is an AI healthcare company founded in Melbourne, Australia, serving clinicians with documentation and care workflow automation; the company said the round would help expand its teams and operations across priority markets, while continuing to localize the platform and build out clinical and engineering capabilities.
Oct 2025Series BPoint72 Ventures (lead); Possible Ventures; Blackbird Ventures; Latitude; Archangel Ventures; Alumni Ventures; Headline$65M$465MHeidi Health is a Melbourne, Australia-based healthcare AI company founded in 2021 that develops an AI-powered clinical documentation platform, acting as a medical scribe to automate administrative tasks like transcribing notes, generating patient summaries, and tracking tasks, thereby reducing clinician burnout and returning hours to patient care. The platform supports over 2 million patient consults weekly across 116 countries and 110 languages, has processed more than 70 million patient visits in 18 months, and adheres to standards like HIPAA, GDPR, SOC2, and ISO27001. It has gained traction with users from solo practitioners to large health systems, including NHS pilots in the UK and endorsement in New Zealand's public health system. On October 6, 2025, Heidi closed a $65 million USD Series B funding round led by Point72 Private Investments, with participation from existing investors Blackbird Ventures, Headline, Latitude (Phoenix Court's growth fund), Possible Ventures, and Archangel Ventures, valuing the company at $465 million post-money and bringing total funding to approximately $96.6-$100 million across rounds including a $16.6 million Series A follow-on in March 2025 and a $5 million seed in 2021. Proceeds will accelerate global expansion, particularly in the US, UK, and Canada, including doubling UK headcount for NHS demand, hiring key executives like Microsoft's former chief medical officer and Plaid's head of revenue, and developing new features like an AI agent for patient follow-ups and AI medical search to compete with players like Abridge ($5.3B valuation), Ambience Healthcare, Epic, OpenEvidence ($3.5B), and Doximity. Heidi differentiates with bottom-up adoption, model-agnostic AI using its own models and Gemini, international presence beyond North America, and no pharmaceutical advertising. The round reflects Heidi's rapid growth from a $100 million valuation in May 2025, highlighting strong product adoption metrics that impressed investors amid a competitive AI scribe market.
Mar 2025Series AHeadline (lead); Possible Ventures; Menlo Ventures; HESTA; LocalGlobe; Blackbird Ventures; Anthropic; Archangel Ventures$17M-Heidi Health raised USD $16.6 million in a Series A follow-on round in March 2025 led by Headline, with participation from LocalGlobe, Anthology (backed by Menlo Ventures and Anthropic), and existing investors Blackbird Ventures, HESTA, Possible Ventures, and Archangel Ventures. The funding aims to accelerate the company's mission to double global healthcare capacity by automating clinicians' administrative tasks, such as note-taking and document generation, which consume over two hours daily on average. Heidi's AI scribe operates in diverse environments, including emergency departments and surgical theaters, unlike tools limited to quiet settings. The capital will expand capabilities beyond scribing to include pre-chart summaries, clinical guideline access, treatment pathways, and patient engagement outside clinics. This supports clinicians in focusing on patient care amid a projected WHO shortfall of 10 million health workers by 2030. In July 2025, Heidi closed a $65 million Series B led by Point72 Private Investments at a $465 million valuation, bringing total funding to approximately $86.6 million, with plans for U.S., UK, and Canada expansion targeting large hospital systems and veterinary markets.
Oct 2023Series ABlackbird Ventures (lead); Possible Ventures; HESTA; Wormhole Capital; Archangel Ventures; Hostplus; Saniel Ventures$6M-Heidi Health raised A$10 million (approximately $6.5 million USD) in a Series A funding round on October 25, 2023, led by Blackbird Ventures with participation from Archangel Ventures, HESTA, Hostplus, Possible Ventures, Saniel Ventures, and Wormhole Capital. The company, founded in 2019 and headquartered in Cremorne, VIC, Australia, develops an AI-powered ambient scribe platform that automates clinical documentation and administrative tasks to reduce clinician burnout. Originally launched as Oscer, it had previously raised a $5 million seed round in August 2021 backed by Blackbird Ventures. This Series A brought early traction in clinician adoption across medical specialties. Subsequent rounds included a $16.6 million Series A follow-on in March 2025 and a $65 million Series B in October 2025 at a $465 million valuation, supported by investors like Headline, LocalGlobe, Latitude, and Point72 Private Investments, with total funding reaching approximately $86.6 million to $88 million.
Aug 2021SeedBlackbird Ventures (lead); January Capital; Possible Ventures; Brendan Hill; Archangel Ventures$4M$15M-

Who has invested in Heidi Health?

18 investors have backed Heidi Health across its funding rounds, including Blackbird Ventures, Possible Ventures, Archangel Ventures, Headline, Point72 Ventures and HESTA.

Lead investors include Blackbird Ventures, General Catalyst, Point72 Ventures and Headline.


Heidi Health Investors

Investors in Heidi Health by funding rounds participated
InvestorHQRoundsRoleFirst check
Blackbird VenturesAustraliaSydney5LeadAug 2021
Possible VenturesGermanyMunich4ParticipantAug 2021
Archangel VenturesAustraliaMelbourne4ParticipantAug 2021
HeadlineUnited StatesSan Francisco, CA3LeadMar 2025
Point72 VenturesUnited StatesNew York City, NY2LeadOct 2025
HESTAAustraliaMelbourne2ParticipantOct 2023
January CapitalSingaporeSingapore1ParticipantAug 2021
General CatalystUnited StatesSan Francisco, CA1LeadSep 2026
Menlo VenturesUnited StatesSan Francisco, CA1ParticipantMar 2025
LocalGlobeUnited KingdomLondon1ParticipantMar 2025
Wormhole CapitalUnited StatesNew York City, NY1ParticipantOct 2023
Phoenix CourtUnited KingdomLondon1ParticipantSep 2026
Brendan HillAustraliaSydney1ParticipantAug 2021

This data is available for Pro users. Sign up to see all 18 Heidi Health investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by Heidi Health

Heidi Health has acquired 1 company to date.

Last acquisition by Heidi Health was on February 23rd 2026. Heidi Health acquired AutoMedica for undisclosed valuation.


Latest Acquisitions by Heidi Health

AutoMedica
Description
AutoMedica is an AI platform automating clinical trial workflows from recruitment to data management. It develops machine learning models for patient matching, protocol optimization, and regulatory compliance in pharmaceutical research.
HQ CountryUnited Kingdom
HQ City
-
Deal Date23 Feb 2026
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Heidi Health acquisitions and their M&A valuation multiples.

Start Free Trial

Heidi Health Competitors

Heidi Health competitors include listed companies like B-Soft Co. and Phreesia, and private ones like Overjet, Tennr, Latent and DocPlanner.

Public and private companies comparable to Heidi Health
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
OverjetUnited StatesBoston, MAPrivate--$712M-
TennrUnited StatesNew York City, NYPrivate--$605M-
LatentUnited StatesSan Francisco, CAPrivate--$600M-
DocPlannerPolandWarsawPrivate--$1B-
B-Soft Co.ChinaChinaPublicly listed$157M($37M)$804M5.0x
PhreesiaUnited StatesUnited StatesPublicly listed$481M$27M$601M1.2x

Heidi Health Public Comps

Heidi Health is still privately-owned, but its public comps include MedicalSystem Technology, HealthStream, Beijing CTJ Info Tech, Hangzhou Pinming Software, Sphere, Rezolve AI, Beijing Haitian Ruisheng, ODDITY Tech, Appier Group and Beijing Deep Glint Tech.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
MedicalSystem Technology$45M$12M18.8x15.4x70.0x61.8x
HealthStream$304M$63M2.7x2.6x13.0x11.0x
Beijing CTJ Info Tech$123M$13M5.4x5.1x52.8x35.4x
Hangzhou Pinming Software$65M$8M12.6x11.9x100.3x-
Sphere$70M$6M14.8x5.9x161.0x104.9x
Rezolve AI$47M($109M)23.3x4.0x(10.0x)(19.4x)
Beijing Haitian Ruisheng$56M$5M14.2x14.5x166.0x-
ODDITY Tech$810M$131M1.5x1.7x9.0x17.9x

This data is available for Pro users. Sign up to see all Heidi Health competitors and their valuation data.

Start Free Trial

Common questions about Heidi Health

When was Heidi Health founded?Heidi Health was founded in 2019.
Where is Heidi Health headquartered?Heidi Health is headquartered in Sydney, Australia.
Is Heidi Health publicly listed?No, Heidi Health is a private, VC-backed company.
What is Heidi Health's valuation?Heidi Health was last valued at $901M in its Series C in September 2026.
How much funding has Heidi Health raised?Heidi Health has raised $431M across 5 funding rounds.
What was Heidi Health's last funding round?Heidi Health's last funding round was a $340M Series C in September 2026, led by Blackbird Ventures and General Catalyst.
Who are Heidi Health's investors?Heidi Health's investors include Blackbird Ventures, Possible Ventures, Archangel Ventures, Headline, Point72 Ventures, HESTA, January Capital, General Catalyst, Menlo Ventures, LocalGlobe and 8 others.
What is Heidi Health's revenue?Heidi Health's latest recorded revenue is $50M (September 2026).
What is Heidi Health's revenue multiple?Heidi Health's latest valuation implies a 18.0x revenue multiple ($901M valuation on $50M of revenue).
Which companies are comparable to Heidi Health?Companies comparable to Heidi Health include Overjet, Tennr, Latent, DocPlanner, B-Soft Co. and Phreesia.
How many companies has Heidi Health acquired?Heidi Health has acquired 1 company, including AutoMedica.

See companies similar to Heidi Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial